The German government rejected claims by U.S. Health Secretary Robert F. Kennedy Jr. that Berlin prosecuted doctors and patients for refusing Covid-19 vaccinations or mask mandates. “The statements made by the U.S. Secretary of Health are completely unfounded, factually incorrect, and must be rejected,” German Health Minister Nina Warken said in a statement late Saturday. “I can happily explain this to him personally,” she said. “At no time during the coronavirus pandemic was there any obligation for doctors to carry out vaccines against Covid-19,” Warken added. “Anyone who did not wish to offer vaccines for medical, ethical or personal reasons were not criminally liable and did not have to fear penalties,” she said. Warken added that “criminal prosecution took place only in cases of fraud and forgery of documents, such as the issuing of false vaccine certificates” or exemption certificates for masks.  “Doctors [in Germany] decide independently and autonomously on the treatment of patients,” the minister stressed, adding that “patients are also free to decide which treatment they wish to receive.” Kennedy said in a video post on Saturday that he had written to Warken after receiving reports that Germany was restricting “people’s abilities to act on their own convictions” in medical decisions. He claimed that “more than a thousand German physicians and thousands of their patients” faced prosecution for issuing exemptions from mask-wearing or Covid-19 vaccination requirements during the pandemic. Kennedy did not provide specific examples or identify the reports he cited, but he said Germany was “targeting physicians who put their patients first” and was “punishing citizens for making their own medical choices.” He accused Berlin of undermining the doctor–patient relationship and replacing it with “a dangerous system that makes physicians enforcers of state policies.” Former German Health Minister Karl Lauterbach also pushed back on the claims, telling Kennedy on X to “take care of health problems in his own country.”

President Donald Trump has told his health secretary, Robert F. Kennedy Jr., to consider aligning the U.S. vaccination schedule with those in Europe, where many countries recommend fewer vaccines. Kennedy has taken up the charge with gusto and is considering advising parents to follow Denmark’s childhood schedule rather than America’s. Many who specialize in vaccination and public health say that would be a mistake. While wealthy European countries do health care comparatively well, they say, there are lots of reasons Americans are recommended more shots than Europeans, ranging from different levels of access to health care to different levels of disease. “If [Kennedy] would like to get us universal health care, then maybe we can have a conversation about having the schedule adjusted,” Demetre Daskalakis, who led the Centers for Disease Control and Prevention’s National Center for Immunization and Respiratory Diseases before resigning in protest in August, told POLITICO. Children, especially those who live in poor and rural areas, would be at greater risk for severe disease and death if the U.S. were to drop shots from its schedule, Daskalakis said. Denmark, for instance, advises immunizing against only 10 of the 18 diseases American children were historically recommended immunizations against. It excludes shots for potentially serious infections, including hepatitis A and B, meningitis and respiratory syncytial virus. Under Kennedy, the government has already changed its hepatitis B vaccine recommendations for newborns this year, even as critics warned the new advice could lead to more chronic infections, liver problems and cancer. The health department points out that the new guidance on hepatitis B — that mothers who test negative for the virus may skip giving their newborn a shot in the hospital — now align more closely with most countries in Europe. Public health experts and others critical of the move say slimmer European vaccine schedules are a cost-saving measure and a privilege afforded to healthier societies, not a tactic to protect kids from vaccine injuries. Kennedy’s interest in modeling the U.S. vaccine schedule after Europe, they point out, is underpinned by his belief that some childhood vaccines are unsafe and that American kids get too many too young. Kennedy’s safety concerns don’t align with the rationale underpinning the approach in Europe, where the consensus is that childhood vaccines are safe. Wealthy European countries in many cases eschew vaccines based on a risk-benefit calculus that doesn’t hold in America. European kids often don’t get certain shots because it would prevent a very small number of cases — like hepatitis B — or because the disease is rarely serious for them, such as Covid-19 and chickenpox. But since the U.S. doesn’t have universal access to care, vaccinating provides more return on investment, experts say. “We just have a tradition to wait a little bit” before adding vaccines to government programs, said Johanna Rubin, a pediatrician and vaccine expert for Sweden’s health agency. Swedish children are advised to get vaccines for 11 diseases before they turn 18. Rubin cited the need to verify the shots’ efficacy and the high cost of new vaccines as reasons Sweden moves slowly to add to its schedule. “It has to go through the health economical model,” she said. VACCINE SAFETY’S NOT THE ISSUE Martin Kulldorff, a Swedish native and former Harvard Medical School professor who led Kennedy’s vaccine advisory panel until this month, pointed to that country’s approach to vaccination and public health in an interview with POLITICO earlier this year. Before the Centers for Disease Control and Prevention this month dropped its recommendation that children of mothers who test negative for hepatitis B receive a vaccine within a day of birth, Kulldorff cited Sweden’s policy. “In Sweden, the recommendation is that you only do that if the mother has the infection. That’s the case in most European countries,” he said. “You could have a discussion whether one or the other is more reasonable.” The U.S. policy, as of Dec. 16, more closely resembles Sweden’s, with hepatitis B-negative mothers no longer urged to vaccinate their newborns against the virus at birth. But Sweden’s public health agency recommends that all infants be vaccinated, and the country’s regional governments subsidize those doses, which are administered as combination shots targeting six diseases starting at 3 months. Public health experts warn that even children of hepatitis B-negative mothers could catch the virus from others via contact with caregivers who are positive or shared household items. The prevalence of chronic hepatitis B in the U.S. is 6.1 percent compared to 0.3 percent in Sweden, according to the Coalition for Global Hepatitis Elimination, a Georgia-based nonprofit which receives funding from pharmaceutical companies, the CDC and the National Institutes of Health, among others. Michael Osterholm, the director of the Center for Infectious Disease Research and Policy at the University of Minnesota, said the U.S. has taken a more comprehensive approach to vaccination, in part because its population is sicker than that of some Western European countries, and the impact of contracting a disease could be more detrimental. Osterholm pointed to the Covid pandemic as an example. By May 2022, the U.S. had seen more than 1 million people die. Other high-income countries — though much smaller — had more success controlling mortality, he said. “People tried to attribute [the disparity] to social, political issues, but no, it was because [peer nations] had so many more people who were actually in low-risk categories for serious illness,” Osterholm said. Kennedy and his advisers also cited European views on Covid vaccination in the spring when the CDC dropped its universal recommendation, instead advising individuals to talk to their providers about whether to get the shot. Last month, the Food and Drug Administration’s top vaccine regulator, Vinay Prasad, linked the deaths of 10 children to Covid vaccination without providing more detailed information about the data behind his assertion. European countries years ago stopped recommending repeat Covid vaccination for children and other groups not considered at risk of becoming severely sick. Covid shots have been linked to rare heart conditions, primarily among young men. European vaccine experts say Covid boosters were not recommended routinely for healthy children in many countries — not because of safety concerns, but because it’s more cost-effective to give them to high-risk groups, such as elderly people or those with health conditions that Covid could make severely sick and put in the hospital. In the U.K., Covid-related hospitalizations and deaths declined significantly after the pandemic, and now are “mostly in the most frail in the population, which has led to more restricted use of the vaccines following the cost-effectiveness principles,” said Andrew Pollard, the director of the Oxford Vaccine Group in the United Kingdom, which works on developing vaccines and was behind AstraZeneca’s Covid-19 shot. Pollard led the Joint Committee on Vaccination and Immunization, which advises the U.K. government, for 12 years before stepping down in September. In the U.S., more moves to follow Europe are likely. At a meeting of Kennedy’s vaccine advisers earlier this month, Tracy Beth Høeg, now acting as the FDA’s top drug regulator, pointed to Denmark’s pediatric schedule, which vaccinates for 10 diseases, while questioning whether healthy American children should be subject to more vaccines than their Danish counterparts. Danish kids typically don’t get shots for chickenpox, the flu, hepatitis A and B, meningitis, respiratory syncytial virus and rotavirus, like American children do, though parents can privately pay for at least some of those vaccines. The country offers free Covid and flu vaccines to high-risk kids. After the vaccine advisory meeting wrapped, Trump said he was on board, directing Kennedy to “fast track” a review of the U.S. vaccine schedule and potentially align it with other developed nations. He cited Denmark, Germany and Japan as countries that recommend fewer shots. Last week, Kennedy came within hours of publicly promoting Denmark’s childhood vaccine schedule as an option for American parents. The announcement was canceled at the last minute after the HHS Office of the General Counsel said it would invite a lawsuit the administration could lose, a senior department official told POLITICO. The notion that the U.S. would drop its vaccine schedule in favor of a European one struck health experts there as odd. Each country’s schedule is based on “the local situation, so the local epidemiology, structure of health care services, available resources, and inevitably, there’s a little bit of political aspect to it as well,” said Erika Duffell, a principal expert on communicable disease prevention and control at the European Centre for Disease Prevention and Control, an EU agency that monitors vaccine schedules across 30 European countries. Vaccine safety isn’t the issue, she said. For example, even though most Europeans don’t get a hepatitis B shot within 24 hours of birth, the previous U.S. recommendation, “there is a consensus that the effectiveness and safety of the vaccine has been confirmed through decades of research” and continuous monitoring, she said. European nations like Denmark and the U.K. have kept new cases of hepatitis B low. Denmark recorded no cases of mother-to-child transmission in 2023, and Britain’s rate of such spread is less than 0.1 percent — though the latter does routinely recommend vaccinating low-risk infants beginning at 2 months of age. European experts point to high levels of testing of pregnant women for hepatitis B and most women having access to prenatal care as the reasons for success in keeping cases low while not vaccinating all newborns. The major differences between the U.S. and the U.K. in their approach to hepatitis B vaccination are lower infection rates and high screening uptake in Britain, plus “a national health system which is able to identify and deliver vaccines to almost all affected pregnancies selectively,” Pollard said. The CDC, when explaining the change in the universal birth dose recommendation, argued the U.S. has the ability to identify nearly all hepatitis B infections during pregnancy because of ”high reliability of prenatal hepatitis B screening,” which some European experts doubt. “If we change a program, we need to prepare the public, we need to prepare the parents and the health care providers, and say where the evidence comes from,” said Pierre Van Damme, the director of the Centre for the Evaluation of Vaccination at the University of Antwerp in Belgium. He suggested that, if there was convincing evidence, U.S. health authorities could have run a pilot study before changing the recommendation to evaluate screening and the availability of testing at birth in one U.S. state, for example. WHERE EUROPEANS HAVE MORE DISEASE In some cases, European vaccination policies have, despite universal health care, led to more disease. France, Germany and Italy moved from recommending to requiring measles vaccination over the last decade after outbreaks on the continent. The U.S., until recently, had all but eradicated measles through a universal recommendation and school requirements. That’s starting to change. The U.S. is at risk of losing its “measles-elimination” status due to around 2,000 cases this year that originated in a Texas religious community where vaccine uptake is low. The 30 countries in the European Union and the European Economic Area, which have a population of some 450 million people combined, reported more than 35,000 measles cases last year, concentrated in Romania, Austria, Belgium and Ireland. Europe’s comparatively high rate is linked to lower vaccination coverage than the level needed to prevent outbreaks: Only four of the 30 countries reached the 95-percent threshold for the second measles dose in 2024, according to the European Centre for Disease Prevention and Control. Kennedy touted the U.S.’s lower measles rate as a successful effort at containing the sometimes-deadly disease, but experts say the country could soon see a resurgence of infectious diseases due to the vaccine skepticism that grew during the pandemic and that they say Kennedy has fomented. Among kindergarteners, measles vaccine coverage is down 2.7 percentage points as of the 2024-2025 school year, from a peak of 95.2 percent prior to the pandemic, according to CDC data. That drop occurred before Kennedy became health secretary. Kennedy and his advisers blame it on distrust engendered by Covid vaccine mandates imposed by states and President Joe Biden. But Kennedy led an anti-vaccine movement for years before joining the Trump administration, linking shots to autism and other conditions despite scientific evidence to the contrary, and he has continued to question vaccine safety as secretary. In some EU nations, vaccines aren’t compulsory for school entry. Swedish law guarantees the right to education and promotes close consultation between providers and patients. Some governments fear mandates could push away vaccine-hesitant parents who want to talk the recommended shots over with their doctor before giving the vaccines to their children, Rubin explained. In the U.S., states, which have the authority to implement vaccine mandates for school entry, rely on the CDC’s guidance to decide which to require. Vaccine skeptics have pushed the agency to relax some of its recommendations with an eye toward making it easier for American parents to opt out of routine shots. Scandinavian nations maintain high vaccine uptake without mandates thanks to “high trust” in public health systems, Rubin said. In Sweden, she added, nurses typically vaccinate young children at local clinics and provide care for them until they reach school age, which helps build trust among parents. CHICKENPOX Another example of where the U.S. and Europe differ is the chickenpox vaccine. The U.S. was the first country to begin universal vaccination against the common childhood illness in 1995; meanwhile, 13 EU nations broadly recommend the shot. Denmark doesn’t officially track chickenpox — the vaccine isn’t included on its schedule — but estimates 60,000 cases annually in its population of 6 million. The vastly larger U.S. sees fewer than 150,000 cases per year, according to the CDC. Many European countries perceive chickenpox as a benign disease, Van Damme said. “If you have a limited budget for prevention, you will spend usually the money in other preventative interventions, other vaccines than varicella,” he said, referring to the scientific term for chickenpox. But there’s another risk if countries decide to recommend chickenpox vaccination, he explained. If the vaccination level is low, people remain susceptible to the disease, which poses serious risks to unborn babies. If it’s contracted in early pregnancy, chickenpox could trigger congenital varicella syndrome, a rare disorder that causes birth defects. If children aren’t vaccinated against chickenpox, almost all would get the disease by age 10, Van Damme explained. If countries opt for vaccination, they have to ensure robust uptake: vaccinate virtually all children by 10, or risk having big pockets of unvaccinated kids who could contract higher-risk infections later. Europe’s stance toward chickenpox could change soon. Several countries are calculating that widely offering chickenpox vaccines would provide both public health and economic benefits. Britain is adding the shot to its childhood schedule next month. Sweden is expected to green-light it as part of its national program in the coming months. While the public doesn’t see it as a serious disease, pediatricians who see serious cases of chickenpox are advocating for the vaccine, Rubin told POLITICO. “It is very contagious,” she said. “It fulfills all our criteria.” The U.K. change comes after its vaccine advisory committee reviewed new data on disease burden and cost-effectiveness — including a 2022 CDC study of the U.S. program’s first 25 years that also examined the vaccine’s impact on shingles, a painful rash that can occur when the chickenpox virus reactivates years later. Scientists had theorized for years that limiting the virus’ circulation among children could increase the incidence of shingles in older adults by eliminating the “booster” effect of natural exposure, but the U.S. study found that real-world evidence didn’t support that hypothesis.

LONDON — A mutated influenza strain is spreading early in Europe this winter, but some experts warn talk of a “superflu” is misleading, erodes public trust and distracts from the underlying problems of the National Health Service. The new strain has triggered dramatic headlines in the U.K., where health leaders are warning of a “worst-case scenario” for the country’s NHS. Health Secretary Wes Streeting described it as a “tidal wave of flu tearing through our hospitals” and labelled it a “challenge unlike any [the NHS] has seen since the pandemic.” While hospital admissions have been rising sharply due to the early arrival of flu season, there is currently no evidence that this season’s variant is more deadly or transmissible, experts at the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC) told POLITICO. Neither does the data suggest hospital admissions will peak higher than previous years — although this is possible — just that they’re a few weeks early. But some experts in the U.K. have criticized the government’s “superflu” narrative, suggesting it’s being used as leverage in talks on doctor pay and conditions ahead of a looming strike. Prime Minister Keir Starmer wrote in The Guardian Friday it was “beyond belief” doctors would consider striking in these “potentially dire” circumstances, citing “a superflu epidemic.” The British Medical Association (BMA), the union representing resident doctors due to go on strike Wednesday, claimed it was “irresponsible to portray the current winter flu crisis as unprecedented” given that rates of infection and hospitalization were “comparable to most years,” a spokesperson told POLITICO. Mathematician Christina Pagel, a professor at University College London, said the “superflu” line was based on the “highly misleading use of statistics” and had more to do with the impending doctors’ strike than real trends. When contacted by POLITICO, the U.K. government stood by its health leaders’ warnings of the current flu season, in which they described it as an “unprecedented wave of super flu.” They said staff were being “pushed to the limit.” The government also pointed to stats showing the NHS is under pressure. A DHSC spokesperson told POLITICO the government had offered the BMA an extended mandate so they could strike in January instead, but the union rejected it. The BMA told POLITICO the extension included “several restrictive conditions.” THE IMPORTANCE OF TRUST The government and NHS bosses have warned the heavy burden on hospitals in December could set the health system up for a very severe winter. NHS statistics published last week show an average of 2,660 patients in hospital with flu per day, a record for this time of year, while the Health Foundation has said the NHS could face “major pressures” if cases continue to climb rapidly in the weeks ahead. Yet, while NHS staff are stretched, Pagel and others argue this year is largely consistent with previous severe flu seasons. However, without being clear about this with the public, some experts are concerned the government’s messaging could do more harm than good. “One of the real issues we have with governments everywhere is trust,” Martin McKee, professor of public health at the London School of Hygiene and Tropical Medicine, told POLITICO. While NHS staff are stretched, experts argue this year is largely consistent with previous severe flu seasons. | Geography Photos/Getty Images “The difficulty is we’ve seen them do all sorts of things for all sorts of motives. That then becomes a problem whenever they are saying something accurate,” McKee said, adding that the government should be more careful in its flu messaging given the declining trust in science. POLITICO put these concerns over trust in science to DHSC, but the department did not respond by the time of publication. A spokesperson for government-sponsored NHS England told POLITICO: “The NHS is not misleading the public — this is the earliest flu season we have seen in recent years with the latest data showing the numbers of patients in hospital with flu is extremely high for this time of year.” The NHS is struggling as it often does in winter, with a spike in delayed discharges — people who are ready to leave hospital but have nowhere to go — posing an extra challenge for hospitals, The Guardian reported Sunday. Hospital admissions for flu per 100,000 rose 23 percent in last week’s data, compared to 69 percent the previous week, but this doesn’t rule out another surge in the weeks ahead. McKee said the NHS was paying the price for chronic underinvestment. “We almost seem surprised that it’s arrived,” he said of the current flu wave, citing a “massive shortage” in beds, IT equipment and scanners.  WHAT THE EXPERTS SAY There is no reason to think the current flu strain (H3N2 sub-clade K) causes more severe disease than other types of flu, Hans Kluge, head of the World Health Organization’s Europe office, told POLITICO. Nor is there any solid evidence that it is more transmissible, said Edoardo Colzani, a flu expert at the European Centre for Disease Prevention and Control. It’s possible the lower level of immunity to this strain could lead to more cases “but this is still speculative at this stage,” Colzani said. “The epidemiological situation at the moment [in the EU] does not seem worse than in previous years apart from the fact that it is two-to-three weeks earlier,” Colzani said. Kluge said it was “about 4 weeks earlier than usual,” which “is not out of the ordinary” and trending similar to the 2022–2023 influenza season. There were some concerns the available flu vaccine might not be a “perfect match” for the current strain, Kluge said, but early data from the U.K. suggests it provides “meaningful protection” and may prevent severe disease and death, especially among vulnerable groups. “We [could] end up having a much bigger wave than usual but we have no evidence,” Pagel said, adding she thought it was “most likely” to peak “in a couple of weeks.” But the available data can’t tell us whether it will be a normal wave that starts and ends early, or an especially bad season, she added.  “We don’t know when it will turn the corner but the actual shape of the wave doesn’t look that different from previous years,” McKee said. The NHS has previously warned of the risk of a “long and drawn-out flu season” due to the early start. According to the WHO, some countries in the southern hemisphere had unusually long flu seasons this year.  “Based on previous trends, this season is expected to peak in late December or early January,” Kluge said. The advice from EU and U.K. authorities remains the same — get a flu vaccine as soon as possible, especially for those in a vulnerable group.

When the Franco-German summit concluded in Berlin, Europe’s leaders issued a declaration with a clear ambition: strengthen Europe’s digital sovereignty in an open, collaborative way. European Commission President Ursula von der Leyen’s call for “Europe’s Independence Moment” captures the urgency, but independence isn’t declared — it’s designed. The pandemic exposed this truth. When Covid-19 struck, Europe initially scrambled for vaccines and facemasks, hampered by fragmented responses and overreliance on a few external suppliers. That vulnerability must never be repeated. True sovereignty rests on three pillars: diversity, resilience and autonomy. > True sovereignty rests on three pillars: diversity, resilience and autonomy. Diversity doesn’t mean pulling every factory back to Europe or building walls around markets. Many industries depend on expertise and resources beyond our borders. The answer is optionality, never putting all our eggs in one basket. Europe must enable choice and work with trusted partners to build capabilities. This risk-based approach ensures we’re not hostage to single suppliers or overexposed to nations that don’t share our values. Look at the energy crisis after Russia’s illegal invasion of Ukraine. Europe’s heavy reliance on Russian oil and gas left economies vulnerable. The solution wasn’t isolation, it was diversification: boosting domestic production from alternative energy sources while sourcing from multiple markets. Optionality is power. It lets Europe pivot when shocks hit, whether in energy, technology, or raw materials. Resilience is the art of prediction. Every system inevitably has vulnerabilities. The key is pre-empting, planning, testing and knowing how to recover quickly. Just as banks undergo stress tests, Europe needs similar rigor across physical and digital infrastructure. That also means promoting interoperability between networks, redundant connectivity links (including space and subsea cables), stockpiling critical components, and contingency plans. Resilience isn’t theoretical. It’s operational readiness. Finally, Europe must exercise authority through robust frameworks, such as authorization schemes, local licensing and governance rooted in EU law. The question is how and where to apply this control. On sensitive data, for example, sovereignty means ensuring it’s held in Europe under European jurisdiction, without replacing every underlying technology component. Sovereign solutions shouldn’t shut out global players. Instead, they should guarantee that critical decisions and compliance remain under European authority. Autonomy is empowerment, limiting external interference or denial of service while keeping systems secure and accountable. But let’s be clear: Europe cannot replicate world-leading technologies, platforms or critical components overnight. While we have the talent, innovation and leading industries, Europe has fallen significantly behind in a range of key emerging technologies. > While we have the talent, innovation and leading industries, Europe has fallen > significantly behind in a range of key emerging technologies. For example, building fully European alternatives in cloud and AI would take decades and billions of euros, and even then, we’d struggle to match Silicon Valley or Shenzhen. Worse, turning inward with protectionist policies would only weaken the foundations that we now seek to strengthen. “Old wines in new bottles” — import substitution, isolationism, picking winners — won’t deliver competitiveness or security. Contrast that with the much-debated US Inflation Reduction Act. Its incentives and subsidies were open to EU companies, provided they invest locally, develop local talent and build within the US market. It’s not about flags, it’s about pragmatism: attracting global investments, creating jobs and driving innovation-led growth. So what’s the practical path? Europe must embrace ‘sovereignty done right’, weaving diversity, resilience and autonomy into the fabric of its policies. That means risk-based safeguards, strategic partnerships and investment in European capabilities while staying open to global innovation. Trusted European operators can play a key role: managing encryption, access control and critical operations within EU jurisdiction, while enabling managed access to global technologies. To avoid ‘sovereignty washing’, eligibility should be based on rigorous, transparent assessments, not blanket bans. The Berlin summit’s new working group should start with a common EU-wide framework defining levels of data, operational and technological sovereignty. Providers claiming sovereign services can use this framework to transparently demonstrate which levels they meet. Europe’s sovereignty will not come from closing doors. Sovereignty done right will come from opening the right ones, on Europe’s terms. Independence should be dynamic, not defensive — empowering innovation, securing prosperity and protecting freedoms. > Europe’s sovereignty will not come from closing doors. Sovereignty done right > will come from opening the right ones, on Europe’s terms. That’s how Europe can build resilience, competitiveness and true strategic autonomy in a vibrant global digital ecosystem.

Rick Pazdur, the FDA’s top drug regulator, told staff Tuesday he submitted his resignation to the agency, an abrupt departure weeks after he was convinced by Commissioner Marty Makary to take the post to help bring stability to an agency reeling from months of upheaval, according to four people familiar with the decision granted anonymity to discuss the move. The decision — which comes days after top vaccine regulator Vinay Prasad said the agency would ratchet up regulatory requirements for new vaccines — is almost certain to raise new questions about Makary’s leadership of the FDA. Pazdur in recent weeks clashed with Makary over the Commissioner’s National Priority Voucher program, according to media reports. That program — which aims to speed final review of drugs that address health priorities, pose a transformative innovative impact, address an unmet medical need, help onshoring efforts or increase affordability — was also criticized by Pazdur’s predecessor, George Tidmarsh. FDA experts have worried the involvement of political appointees in the process of choosing which firms receive a voucher could raise questions about the program’s integrity. STAT first reported the news of Pazdur’s decision to retire. It is unclear if the decision is final — one person familiar with the decision said the longtime cancer drug regulator has 30 days to change his decision. “We respect Dr. Pazdur’s decision to retire and honor his 26 years of distinguished service at the FDA,” an FDA spokesperson said in a statement. “As the founding director of the Oncology Center of Excellence, he leaves a legacy of cross-center regulatory innovation that strengthened the agency and advanced care for countless patients. His leadership, vision, and dedication will continue to shape the FDA for years to come.” The White House and Pazdur did not immediately respond to requests for comment. Pazdur, a 26-year agency veteran, initially rebuffed efforts by Makary to convince him to assume leadership of the FDA’s Center for Drug Evaluation and Research — but ultimately agreed to take the job after being assured he would be given autonomy in the role free from political influence and the ability to rehire staff.

Pediatric respiratory diseases are among the most common and serious health challenges we face worldwide. From examples such as respiratory syncytial virus (RSV) to pertussis (also known as whooping cough), these infections can cause significant illness, hospitalizations, and with some, possible long-term consequences.[1],[2] Worldwide, RSV causes approximately 3.6 million hospitalizations and 100,000 deaths each year in children under five years of age.[3] Yet, many of these infections may be prevented, if we continue to prioritize and strengthen immunization. Immunization is not just a scientific achievement; it’s a public health imperative. And in this new era, Sanofi is at the forefront, driving innovation and access to pediatric immunization, especially when it comes to respiratory disease prevention. Our commitment is global, our ambition bold: to help protect people everywhere against preventable illnesses, with the confidence that every child, every parent, every person, and every healthcare professional deserves. > Immunization is not just a scientific achievement; it’s a public health > imperative. RSV, a leading cause of infant hospitalizations globally, exemplifies both the challenge and the opportunity.[4],[5],[6],[7] With an estimated 12.9 million lower respiratory infections and 2.2 million hospitalizations annually among infants under one year of age,3 the burden is immense. For decades, RSV lacked preventive options for the broad infant population. Some countries in Europe are a good illustration of what is possible when prevention is prioritized. For example, in Galicia, Spain, implementation of a universal program offered to the broad infant population led to notable reductions in RSV-related hospitalization compared with previous seasons.[8] The lesson is clear: when prevention is prioritized like it matters, delivered equitably and integrated into routine care, the impact is quickly seen. This principle applies to other childhood respiratory diseases. Hexavalent combination vaccinations have helped to revolutionize pediatric immunization by combining protection against six diseases into one vaccine. One of these is pertussis, which is especially dangerous for children who haven’t received all their vaccinations yet, and have a four-fold higher risk of contracting whooping cough.[9]  For younger infants pertussis is high risk, with over 40 percent of infants under six months of age requiring hospitalization.[10] These data demonstrate how delayed or missed vaccine doses can leave children vulnerable. By combining vaccines into a single shot, immunization uptake can be improved, increasing acceptance with efficient and equitable delivery and helping reduce disease burden at scale.[11],[12] > Some countries in Europe are a good illustration of what is possible when > prevention is prioritized. For example, in Galicia, Spain, implementation of a > universal program offered to the broad infant population led to notable > reductions in RSV-related hospitalization compared with previous seasons. Good uptake is crucial for protecting children. Where programs are fragmented, under-resourced or underfunded, equity gaps worsen along familiar lines – income, access and information. The recent resurgence of some preventable diseases is not just a warning; it’s a call to action.[13],[14],[15] Sustaining protection against respiratory diseases in children, increasing vaccination coverage rates, and embracing innovation to help protect against more diseases must be a collective priority.[11],[12] We must not let misinformation or complacency erode public trust in immunization. The evidence is clear: prevention works. Today, we have a unique opportunity to showcase that impact and redefine the future of respiratory health in children. > We must not let misinformation or complacency erode public trust in > immunization. The evidence is clear: prevention works. The science is sound. The approach for protecting infants against respiratory infections is clear. Our children deserve nothing less. -------------------------------------------------------------------------------- [1] Glaser EL, et al. Impact of Respiratory Syncytial Virus on Child, Caregiver, and Society. Journal of Infectious Diseases. 2022;226(Supplement_2):S236-S241 [2] Kardos P, et al. Understanding the impact of adult pertussis and its complications. Hum Vaccin Immunother. 2024. [3] Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 2022;399:2047-2064. [4] Leader S, Kohlhase K. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. The Pediatric infectious disease journal. 2002;21(7):629-32. [5] McLaurin KK, Farr AM, Wade SW, Diakun DR, Stewart DL. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants. Journal of Perinatology: official journal of the California Perinatal Association. 2016;36(11):990-6. [6] Rha B, et al. Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics. 2020;146:e20193611. [7] Arriola CS, et al. Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15. J Pediatric Infect Dis Soc. 2020;9:587-595. [8] Ares-Gómez S, et al. NIRSE-GAL Study Group. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study. Lancet Infectious Diseases. 2024; 24: 817-828. [9] Centers for Disease Control and Prevention. 2019 Final Pertussis Surveillance Report. Accessed 4 March 2025 [10] Glanz, J. M., et al. (2013) Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. JAMA Pediatr. doi: 10.1001/jamapediatrics.2013.2353 [11] Fatima M, Hong KJ. Innovations, Challenges, and Future Prospects for Combination Vaccines Against Human Infections. Vaccines (Basel). 2025 Mar 21;13(4):335. doi: 10.3390/vaccines13040335. PMID: 40333234; PMCID: PMC12031483. [12] Maman K, Zöllner Y, Greco D, Duru G, Sendyona S, Remy V. The value of childhood combination vaccines: From beliefs to evidence. Hum Vaccin Immunother. 2015;11(9):2132-41. doi: 10.1080/21645515.2015.1044180. PMID: 26075806; PMCID: PMC4635899. [13] Liu J, Lu G, Qiao J. Global resurgence of pertussis in infants BMJ 2025; 391 :r2169 doi:10.1136/bmj.r2169 [14] Jenco M. AAP, CHA call for emergency declaration to address surge of pediatric illnesses. AAP News. 2022 [15] Wang, S., Zhang, S., & Liu, J. (2025). Resurgence of pertussis: Epidemiological trends, contributing factors, challenges, and recommendations for vaccination and surveillance. Human Vaccines & Immunotherapeutics, 21(1). https://doi.org/10.1080/21645515.2025.2513729 MAT-GLB-2506084 

LONDON — Keir Starmer’s gone all-in on digital identification for Brits. But while many MPs in the prime minister’s governing Labour Party back the idea in theory, there are plenty despairing at a botched communications strategy which they believe has set the wide-ranging policy up for a fall. Under Starmer’s plans, digital ID will be required for right-to-work checks by 2029. Ministers insist the ID — a second attempt to land ID cards for Brits after a botched first go under Tony Blair — won’t track people’s location, spending habits or online activity.  Yet Labour MPs feel a more sellable emphasis on improving people’s experience of public services has gotten lost. Instead, Starmer’s government — with populist right-winger Nigel Farage breathing down its neck — has attempted to link the plan to a migration crackdown. “It’s a no-brainer,” said Labour MP Allison Gardner, chair of the All Party Parliamentary Group (APPG) for digital identity. “It absolutely will make people’s lives easier, more secure [and] give them more control over their data. We need to explain it better to people, so that they understand that this is for them, and it’s not being done to them.” HARD SELL  A consultation on the plans will be launched by the end of 2025, before legislation next year. The government’s huge majority means it’s highly likely to become law — but there’s a potentially bumpy road ahead. Two decades after Blair’s New Labour first proposed plastic identity cards, Starmer wants to finish the job, pitching a plan to make digital ID mandatory for right-to-work checks as a way to deter irregular migration. Yet the sweeping change, announced on the eve of Labour conference, didn’t get a mention in Starmer’s setpiece speech — and notably didn’t appear in the party’s election manifesto. “The announcement hasn’t been handled well,” admitted a pro-digital ID Labour MP granted anonymity to speak candidly. “Our argument for it keeps changing but none of it is full-throated enough.” The messaging has shifted since the initial push, too. Technology Secretary Liz Kendall later stressed giving “people power and control over their lives,” saying the public is too often “at the mercy of a system that does not work for us as well as it should.” That was only after a drop in poll ratings for the idea. A petition against it has meanwhile racked up close to three million signatures. The shapeshifting rhetoric — painting digital ID first as a necessary inconvenience before calling it vital for state efficiency — caused some heads to spin. Technology Secretary Liz Kendall later stressed giving “people power and control over their lives,” saying the public is too often “at the mercy of a system that does not work for us as well as it should.” | Andy Rain/EPA “The government communication … has not learned from the mistakes made when digital ID was proposed 20 years ago,” said a second Labour MP, who thought the focus on immigration meant ministers weren’t “talking about the benefits it brings ordinary British citizens.”  Red flags have also been also waved over compulsory right-to-work checks, given only the very wealthiest Brits never need to work — making it de facto mandatory. “There’s been a kneejerk reaction, particularly to the word mandatory, which I think British people have naturally reacted against,” admitted Gardner, who argues voters should have a choice about using the scheme. “It’s a little bit of a bandwagon people have latched on to, to actually derail the entire concept.”  Farage, eager to paint himself as a champion of civil liberties, has warned digital ID won’t stop “illegal immigration”  but will “be used to control and penalise the rest of us.” Analysis by the New Britain Project think tank, shared with POLITICO, shows that Google searches for digital ID were elevated for around three weeks after the announcement compared to the typical one day spike for most policies. Interest dwarfed other decisions too, with peak search traffic for digital ID 20 to 50 times higher than any other flagship policy terms in the last year. Nigel Farage, eager to paint himself as a champion of civil liberties, has warned digital ID won’t stop “illegal immigration” but will “be used to control and penalise the rest of us.” | Neil Hall/EPA Longstanding Labour MP Fabian Hamilton highlights the dilemma of digital ID: “Nobody likes compulsion, and it will only work if everybody has to have it.” Despite Kendall expressing optimism about a digital key unlocking “better, more joined-up and effective public services,” Hamilton argues that prioritizing migration in the messaging is too simplistic. “I’m sorry to say that the legal migration is tilting the head at a certain part of the electorate that are very concerned about illegal migration and the tabloids,” he argues. NO SILVER BULLET  Whether digital ID works on its own terms — reducing irregular migration — is also hotly contested. Right-to-work checks already exist in the U.K., with employees required to show documentation like a letter with their national insurance number. “It may be helpful, but obviously it won’t affect fundamental factors [driving people to the U.K.] of family links or English language,” warns former Home Office Permanent Secretary Philip Rutnam. He believes the most challenging part of the scheme will be “establishing the status of many people beyond doubt” given some residents may not have formal ID. “There are millions of people whose status it may bring into question,” Rutnam says. “Their status may not be what they have understood it to be.” Whether digital ID works on its own terms — reducing irregular migration — is also hotly contested. | Tolga Akmen/EPA That’s sparked fears among some in Westminster of another Windrush scandal. That debacle saw some people who emigrated to Britain as part of a post-Second World War rebuilding effort later denied rights and, in the most extreme cases, deported under a scattershot Home Office clampdown.  “We need to be very, very careful,” warns former U.K. Border Force Director-General Tony Smith. Smith says digital ID is “not a panacea,” and warns illegal working is likely to remain because unscrupulous employers won’t suddenly become law-abiding. TECH TROUBLES The British government’s ability to handle such a vast amount of sensitive data securely is also far from certain. Kendall has stressed that the data behind digital ID won’t be centralized and says individuals will be able to see who has accessed their information. That’s not enough for skeptics.  A catastrophic Ministry of Defence breach, which leaked details of Afghans applying to resettle in Britain after the Taliban’s return to power, shows the danger of sensitive details reaching the wrong hands. “The track record’s not been great,” Smith warns. “You are trying to turn round a huge tanker in the ocean here, and I do worry that we haven’t perhaps got the necessary gear.”  Rutnam agrees digital ID will be a “very demanding administrative exercise” that politicians need to understand is “complex and inherently risky.”  A catastrophic Ministry of Defence breach, which leaked details of Afghans applying to resettle in Britain after the Taliban’s return to power, shows the danger of sensitive details reaching the wrong hands. | Andy Rain/EPA Perhaps more damning for digital ID’s support among the Labour faithful is anxiety about future governments using the information malevolently. “Faith in our institutions of government and of the state is at an all-time low,” says Hamilton, citing a “bizarre situation” where some Brits lump digital ID in with Covid-19 vaccines as a government conspiracy. One Labour MP vehemently opposed to digital ID says ministers are so far failing to consider “what happens when we’re gone” and warns any safeguards “can be unpicked” by subsequent administrations. Starmer has spoken about digital ID as a positive alternative to rifling through drawers looking for “three bills when you want to get your kids into school or apply for this or apply for that.” “F*ck you,” the anonymous Labour MP above said in response. “I can’t believe that. Is that the best you’ve got for giving away fundamental rights?” Still, Gardner is pleading for colleagues not to block this modern innovation: “We are at risk of throwing a very, very good baby out with the bathwater if we resist this and just keep ourselves in the dark ages.” Emilio Casalicchio and Dan Bloom contributed to this report.

BRUSSELS — An adviser to U.S. Health Secretary Robert F. Kennedy Jr. lauded Europe’s data on Covid-19 vaccines in front of European Parliament lawmakers on Wednesday. Robert W. Malone, one of RFK Jr.’s newly selected vaccine advisers to the U.S. Centers for Disease Control and Prevention, said the United States can’t gather and analyze data as well as Europe does it, name-checking the Nordics and the U.K. especially for their systems. “One of the consequences is we can’t do, frankly, as good a job as you can do in epidemiology, which may be part of the reason why in some nation states, we’re getting better data on the Covid harms from Europe, the U.K., than we’re getting from the United States,” Malone said. That’s because, among other things, “we don’t have socialized medicine the same way you do, and we have barriers to ensure patient confidentiality,” he told right-wing MEPs gathered in the Parliament to launch the Make Europe Healthy Again (MEHA) movement with the Patriots for Europe group. Under RFK Jr., the U.S. has tried to reign in who can receive Covid-19 shots, which until recently were offered to everyone over 6 months of age at least once a year.   Europe diverged from American Covid-19 shot recommendations during the pandemic, restricting eligibility to those who would be at greatest risk from catching the virus as well as weighing the possible side effects. Younger men and teenagers, for example, appeared more susceptible to a rare heart condition after vaccination. RFK Jr., who has campaigned against the use of certain vaccines, has cited Europe’s approach to Covid-19 vaccination in his attempts to restrict who in the U.S. should receive it. He has also pushed for pregnant women to avoid using paracetamol (Tylenol), linking its use to increasing rates of autism in the U.S., under his Make America Health Again (MAHA) campaign.

On Wednesday evening, Emily Cleary, a 47-year-old journalist and public relations consultant from Buckinghamshire in the U.K., was sitting watching TV with her 12-year-old son when she got a BBC alert that Charlie Kirk had been shot. She’d never heard of him, but she soon gathered from the coverage that he was associated with President Donald Trump. “You might have seen him, Mummy,” her son insisted. “He’s the man on TikTok with the round face who shouts all the time.” He began filling her in on a long, detailed list of Kirk’s views. “He thinks that if a 10-year-old gets pregnant she should be forced to keep it,” he explained. In the U.S., Kirk was a well-known figure on both sides of the political spectrum thanks to his proximity to the Trump family and profiles in outlets such as POLITICO Magazine and The New York Times Magazine. On the other side of the Atlantic, a schism appeared this week between those perplexed at why Prime Minister Keir Starmer was making statements about a seemingly obscure American podcaster, and those who already viewed him as a celebrity. Debates about the activist’s legacy sprung up in online spaces not usually known for politics, such as Facebook groups intended for sharing Love Island memes or soccer fan communities on X, with some people saying they will “miss his straight talking.” Parents of teens were surprised to find themselves being educated by their children on an issue of apparent international political importance. To some, this was all the more bewildering given the U.K. offshoot of Kirk’s Turning Point was widely mocked as a huge failure when it tried launching at British universities. But Emily’s son learned about Kirk somewhere else: TikTok’s “for you” page. “He hadn’t just seen a few videos, he was very knowledgeable about everything he believed,” she said, adding that her son “didn’t agree with Kirk but thought he seemed like a nice guy.” “It really unnerved me that he knew more about this person’s ideas than I did.” Kirk first rose to prominence in the U.S. when he cofounded Turning Point USA in 2012. It aimed to challenge what it saw as the dominance of liberal culture on American campuses, establishing a network of conservative activists at schools across the country. Kirk built Turning Point into a massive grassroots operation that has chapters on more than 800 campuses, and some journalists have attributed Trump’s 2024 reelection in part to the group’s voter outreach in Arizona and Wisconsin. But across the pond, Turning Point UK stumbled. Formed in 2019, it initially drew praise from figures on the right of the U.K.’s then-ruling Conservative party, such as former member of parliament Jacob Rees-Mogg and current shadow foreign secretary Priti Patel. However, the official launch on Feb. 1 of that year quickly descended into farce: Its X account was unverified, leading student activists from around the country to set up hundreds of satirical accounts. Media post-mortems concluded the organization failed to capture the mood of U.K. politics. The British hard right tends to fall into two categories: the aristocratic eccentricity of Rees-Mogg, or rough-and-ready street-based movements led by figures such as former soccer hooligan (and Elon Musk favorite) Tommy Robinson. Turning Point USA — known for its highly-produced events full of strobe lights, pyrotechnics and thundering music — was too earnest, too flashy, too American. And although U.K. universities tend to be left-leaning, Kirk’s claim that colleges are “islands of totalitarianism” that curtail free speech didn’t seem to resonate with U.K. students like it did with some in the U.S. “For those interested in opposing group think or campus censorship, organisations and publications already exist [such as] the magazine Spiked Online,” journalist Benedict Spence wrote at the time, adding that “if conservatives are to win round young voters of the future, they will have to do so by policy.” Turning Point UK distanced itself from its previous leadership and mostly moved away from campuses, attempting to reinvent itself as a street-based group. However, five years later in early 2024, Kirk launched his TikTok account and quickly achieved a new level of viral fame on both sides of the Atlantic. Clips of his “Debate Me” events, in which he took on primarily liberal students’ arguments on college campuses, exploded on the platform. This also coincided with a shift in the landscape of the British right toward Kirk’s provocative and extremely online style of politics. Discontent had been swelling around the country as the economic damage of Brexit and the Covid-19 pandemic began to bite, and far-right movements distrustful of politicians and legacy media gained traction online. While some of Kirk’s favorite topics — such as his staunch opposition to abortion and support of gun rights — have never resonated with Brits, others have converged. Transgender rights moved from a fringe issue to a mainstream talking point, while debates over immigration became so tense they erupted in a series of far-right race riots in August 2024, largely organized and driven by social media. In this political and digital environment, inflammatory culture-war rhetoric found new purchase — and Kirk was a bona fide culture warrior. He called for “a Nuremberg-style trial for every gender-affirming clinic doctor,” posted on X last week that “Islam is the sword the left is using to slit the throat of America” and regularly promoted the racist “great replacement” conspiracy theory, which asserts that elites are engaged in a plot to diminish the voting and cultural power of white Americans via immigration policy. “The American Democrat Party hates this country. They want to see it collapse. They love it when America becomes less white,” he said on his podcast in 2024. Harry Phillips, a 26-year-old truck driver from Kent, just south of London, began turning to influencers for his news during the pandemic, saying he didn’t trust mainstream outlets to truthfully report information such as the Covid-19 death toll. He first came across Kirk’s TikTok videos in the run-up to the 2024 U.S. presidential election. “I really liked that he was willing to have his beliefs challenged, and that he didn’t do it in an aggressive manner,” he said. “I don’t agree with everything, such as his views on abortion. But I do agree with his stance that there are only two genders, and that gender ideology is being pushed on kids at school.” Through Kirk, Phillips said he discovered other U.S. figures such as far-right influencer Candace Owens and Director of National Intelligence Tulsi Gabbard, whom he now follows on X, as well as more liberal debaters such as TikToker Dean Withers. “America’s such a powerful country, I think we should all keep an eye on what happens there because it can have a knock-on effect here,” he said. University students in the U.K. may not have been concerned about free speech in 2019, but Phillips definitely is. “I believe we’re being very censored by our government in the U.K.,” he said, citing concerns over the numbers of people reportedly arrested for social media posts. He also said Kirk was not just popular with other people his age, but older members of his family too — all of whom are distraught over his death. In May 2025, six years after the original Turning Point U.K. failed to take off, Kirk found his way back to U.K. campuses via the debate societies of elite universities like Oxford and Cambridge. He wasn’t the first far-right provocateur to visit these clubs, which have existed since the 19th century — conservative media mogul Ben Shapiro took part in a Cambridge debate in November 2023. Oxford Union’s most recent president, Anita Okunde, told British GQ these events were an attempt to make the societies, which were widely considered stuffy and stuck-up, “culturally relevant to young people.” Kirk’s hour-long video, “Charlie Kirk vs 400 Cambridge Students and a Professor,” has 2.1 million views on YouTube and has spawned multiple shorter clips, disseminated by his media machine across multiple platforms. Clips from the same debates also exist within a parallel left-wing ecosystem, re-branded with titles such as “Feminist Cambridge Student OBLITERATES Charlie Kirk.” Although Kirk has been lauded in some sections of the media for being open to debate, these videos don’t appear designed to change anyone’s opinion. Both sides have their views reinforced, taking whatever message they prefer to hear. Karen, a British mother in her late 50s who lives on a farm outside the city of Nottingham, said clips of Kirk getting “owned” by progressives are extremely popular with her 17-year-old daughter and her friends. “I had no idea who he was until she reminded me she had shown me some videos before,” said Karen, whose surname POLITICO Magazine is withholding to protect her daughter’s identity from online harassment. “I think he’s a bit too American for them,” she said. “He’s too in-your-face, and they think some of his opinions are just rage-baiting.” The U.K. political landscape is currently in turmoil, with Farage’s Reform U.K. leading the polls at 31 percent while Starmer’s center-left Labour lags behind at 21 percent. Given the unrest at home, it may seem unusual that so many people are heavily engaged with events thousands of miles away in Washington. Social media algorithms play a role pushing content, as do Farage and Robinson’s close relationships with figures such as Trump, Musk and Vice President JD Vance. In any case, young people in the U.K. are as clued into American politics as ever. Cleary’s 12-year-old son’s description of Kirk wasn’t the first time he surprised her with his knowledge of U.S. politics, either: He recently filled her in on Florida’s decision to end vaccine mandates for schoolchildren. “I’m happy that he is inquisitive and he definitely questions things,” she said. However, she wonders if this consumption of politics via social media will shape the way he and his peers view the world for the rest of their lives. “He even says to me, ‘No one my age will ever vote Labour because they’re no good at TikTok,’” she said. “And he says he doesn’t like Reform, but that they made really good social media videos.”

A day after senators of both parties rebuked his health secretary, Robert F. Kennedy Jr., for restricting access to Covid vaccines at a congressional hearing, President Donald Trump praised them, along with some other shots, during an Oval Office event. “A lot of people think that Covid is amazing,” Trump said, referencing the vaccine, not the disease. “You know, there are many people that believe strongly in that.” Trump also said he thought the polio shot was amazing and that “you have to be very careful when you say that some people don’t have to be vaccinated.” Trump was responding to a question from a reporter about Florida officials’ announcement this week that they would be lifting all vaccination requirements in the state, including for schoolchildren. Trump said: “You have vaccines that work. They just pure and simple work. They’re not controversial at all. And I think those vaccines should be used. Otherwise some people are going to catch it and they endanger other people.” Kennedy has long maintained that parents should have the right to refuse vaccinations required by schools, and he has only approved new Covid vaccines for people older than 65 and those with underlying health conditions. Others may no longer get the shots at pharmacies without a prescription depending on the state where they live. Senators at a Finance Committee hearing Thursday, including Republican Bill Cassidy of Louisiana and the chamber’s second-ranking Republican, John Barrasso of Wyoming, both doctors, questioned Kennedy sharply about the changes to vaccine policy. Barrasso cited polling that he said showed the vast majority of Americans supported most vaccines, while Cassidy praised Trump’s Operation Warp Speed, which helped bring the Covid shots to market in record time. Kennedy struggled to explain how he could both be so critical of Covid shots — he once said they were the “deadliest vaccine ever made” – and at the same time agree with Cassidy that Trump deserved credit for helping to develop them. Trump’s endorsement of vaccination also comes two weeks before a government vaccine panel, which Kennedy has stacked with members who share his skepticism of the shots, will meet to consider revisions to the childhood vaccine schedule. Among other issues, the panel is considering whether to change guidance that newborns receive Hepatitis B vaccines. Kennedy has argued against that practice. Though the disease is usually transmitted through sex or infected needles, mothers can pass it to their babies. Kennedy ran a group, Children’s Health Defense, that questions vaccine safety and was involved with litigation against vaccine makers before he dropped out of the 2024 presidential race and endorsed Trump. He’s long believed that an increase in childhood immunizations is connected to rising autism cases, despite abundant evidence to the contrary. Trump named him health secretary shortly after he won the election. Still, in the immediate aftermath of the Senate hearing Thursday, Trump backed Kennedy, saying his health secretary means well and that he appreciated that Kennedy had a different take on health issues than others. Trump also didn’t sound alarmed when Kennedy pulled $500 million in funding for research on the mRNA technology that undergirded the Covid shots last month, saying at the time that Operation Warp Speed was “a long time ago and we’re on to other things.” On Monday, Trump asked drug companies to justify the success of their Covid vaccines with more efficacy data. Moderna, Novavax and Pfizer responded quickly with evidence they said demonstrated the shots saved lives. Trump also supported Kennedy last week by firing Centers for Disease Control and Prevention Director Susan Monarez. Kennedy had picked Monarez for the job and she’d been in it only a month. Monarez said Kennedy pushed her out because she refused to agree in advance to support changes to vaccine guidance recommended by Kennedy’s handpicked vaccine advisory panel. The CDC director ultimately decides what shots to recommend and to whom. Kennedy denied that was why he dismissed her at the Thursday hearing and said Monarez had told him she wasn’t trustworthy. Monarez’s lawyers said that was not true.